Effectiveness of inhaled treprostinil versus standard of care for the treatment of pulmonary hypertension associated with interstitial lung disease: A propensity score-weighted study of the INCREASE trial and registry data from Europe First published 05/07/2024 Last updated 10/09/2024 EU PAS number:EUPAS1000000238 Study Planned